Acute Cholecystitis

Data from the FDA Adverse Reporting System revealed an association between the use of GLP-1 receptor agonists and the onset of acute cholecystitis.

Researchers have found 36 cases of acute cholecystitis associated with the use of GLP-1 receptor agonists in the U.S., according to findings from the FDA Adverse Event Reporting System published in JAMA Internal Medicine.

SAN DIEGO — Statin therapy decreased the risk for developing acute cholangitis among patients with primary sclerosing cholangitis, according to research presented at Digestive Disease Week 2022.